Newsletter Subject

Buy Signals: $7 Stock Poised To Double

From

biotechbreakouts.com

Email Address

kyle@biotechbreakouts.com

Sent On

Thu, Dec 3, 2020 07:48 PM

Email Preheader Text

Dear Trader, There’s still a lot of time left in the trading day… And I’ve still got

Dear Trader, There’s still a lot of time left in the trading day… And I’ve still got my eye on this $7 that’s poised to double very soon, in my opinion. The stock got away from me this morning, but if it pulls back into my buy zone… I’ll alert subscribers I’m ready to pull the trigger, and I’ll be on LIVE to reveal my thesis on this play, as well as my plan. For the last few days, I’ve mentioned to you how insiders have been scooping up shares, and by the looks of this action… I wouldn’t be surprised if they’re at it again. I mean I think there’s a significant catalyst coming up for the stock given the number of shares corporate insiders have purchased in the last two weeks. Corporate insiders buying shares was one of the catalysts that gave me a high-conviction on OPK.* Right now, there’s similar action in this $7 stock. This company is in the consumer defensive sector, and I believe it’s got massive upside potential. Of course, that’s not the only catalyst I see for this stock. It also has stakes in two companies run by some of the most influential celebrities in the game. Combined, these “influencers” have more than 300M followers on Instagram. They also have more than 100M followers on Twitter. We’ve seen how celebrities can move stocks before, and I think the same can happen. That’s why I’ve been stalking this play all day to find the perfect entry, and I’m getting a bit anxious here. [I don’t want you to miss out on this unique learning opportunity](… That’s why I wanted to give y]([ou]([a heads up that I may make a move as soon as the next hour…]( That is, if the stock gets to my buy zone. You have a rare chance to gain access to a year’s worth of my best “longer-term” catalyst plays… As well as my four upcoming POTUS Catalyst Plays, which I’ll trade LIVE (the consumer defensive stock I’ve got my eye on right now is one of those plays)... [At this ridiculously low price.]( [It comes out to just $1 per week, and that’s an absolute no-brainer decision.]( Given how much demand we’ve seen for this, I’ve been forced to limit the number of people I can let in. [So make sure you secure your spot right now before it’s too late.]( Kyle Dennis *Results presented are not typical and may vary from person to person. Please see our full disclaimer here: ragingbull.com/disclaimer RagingBull, LLC 62 Calef Hwy. #233, Lee, NH 03861 [Click Here to stop receiving emails from kyle@biotechbreakouts.com]( [Unsubscribe from all RagingBull emails]( DISCLAIMER: To more fully understand any Ragingbull.com, LLC ("RagingBull") subscription, website, application or other service ("Services"), please review our full disclaimer located at [(. FOR EDUCATIONAL AND INFORMATION PURPOSES ONLY; NOT INVESTMENT ADVICE. AnyRagingBull Service offered is for educational and informational purposes only and should NOT beconstrued as a securities-related offer or solicitation, or be relied upon as personalizedinvestment advice. RagingBull strongly recommends you consult a licensed or registered professional before making any investment decision. RESULTS PRESENTED NOT TYPICAL OR VERIFIED. RagingBull Services may contain information regarding the historical trading performance of RagingBull owners or employees, and/or testimonials of non-employees depicting profitability that are believed to be true based on the representations of the persons voluntarily providing the testimonial. However, subscribers' trading results have NOT been tracked or verified and past performance is not necessarily indicative of future results, and the results presented in this communication are NOT TYPICAL. Actual results will vary widely given a variety of factors such as experience, skill, risk mitigation practices, market dynamics and the amount of capital deployed. Investing in securities is speculative and carries a high degree of risk; you may lose some, all, or possibly more than your original investment. RAGINGBULL IS NOT AN INVESTMENT ADVISOR OR REGISTERED BROKER. Neither RagingBull nor any of its owners or employees is registered as a securities broker-dealer, broker, investment advisor(IA), or IA representative with the U.S. Securities and Exchange Commission, any state securitiesregulatory authority, or any self-regulatory organization. WE MAY HOLD SECURITIES DISCUSSED. RagingBull has not been paid directly or indirectly by the issuer of any security mentioned in the Services. However, Ragingbull.com, LLC, its owners, and itsemployees may purchase, sell, or hold long or short positions in securities of the companies mentioned inthis communication. If you have a current active subscription with Biotech Breakouts you will need to contact us here if you want to cancel your subscription. Opting out of emails does not remove you from your service at BiotechBreakouts.com.

Marketing emails from biotechbreakouts.com

View More
Sent On

31/07/2021

Sent On

31/07/2021

Sent On

17/07/2021

Sent On

09/07/2021

Sent On

08/07/2021

Sent On

08/07/2021

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.